Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.05% dropped 0.70% to $165.80 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.37% rising 0.23% to 4,468.73 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 0.76% to 34,869.63. This was the stock's fifth consecutive day of losses. Johnson & Johnson closed $14.12 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.68% rose 0.03% to $371.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.99% fell 0.37% to $73.18, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.69% fell 2.22% to $44.58. Trading volume (6.3 M) eclipsed its 50-day average volume of 5.6 M.